Breathing not properly 10 years later: What we have learned and what we still need to learn

Journal of the American College of Cardiology

Volumn 60, Issue 4, 2012, Pages 277-282

  Maisel, Alan S ^a,b   Daniels, Lori B ^b  

^a VA SAN DIEGO HEALTHCARE SYSTEM   (United States)

^b UNIVERSITY OF CALIFORNIA SAN DIEGO   (United States)

Author keywords

acute heart failure; BNP; natriuretic peptide; screening

Indexed keywords

ADIPONECTIN; AMINO TERMINAL PRO BRAIN NATRIURETIC PEPTIDE; ATRIAL NATRIURETIC FACTOR; BRAIN NATRIURETIC PEPTIDE; C REACTIVE PROTEIN; CHOLINE; COPEPTIN; CREATINE KINASE MB; ENDOTHELIN; FATTY ACID BINDING PROTEIN; GROWTH DIFFERENTIATION FACTOR 15; INTERCELLULAR ADHESION MOLECULE 1; INTERLEUKIN 6; ISCHEMIA MODIFIED ALBUMIN; LIPOPROTEIN A; LIPOPROTEIN PHOSPHOLIPASE A2; MATRIX METALLOPROTEINASE; MIDREGION PROATRIAL NATRIURETIC PEPTIDE; MYELOPEROXIDASE; MYOGLOBIN; OSTEOPONTIN; OSTEOPROTEGERIN; PENTRAXIN 3; PHOSPHOLIPASE A2; PLACENTAL GROWTH FACTOR; PROCOLLAGEN; PROCOLLAGEN 3; TROPONIN; TUMOR NECROSIS FACTOR ALPHA; UNCLASSIFIED DRUG;

ACUTE HEART FAILURE; CARDIOVASCULAR DISEASE; CARDIOVASCULAR RISK; CARDIOVASCULAR SYSTEM EXAMINATION; DIAGNOSTIC ACCURACY; DISEASE MARKER; DYSPNEA; HEART INFARCTION; HOSPITAL DISCHARGE; HOSPITAL PATIENT; HUMAN; OUTPATIENT; OUTPATIENT CARE; PATIENT ASSESSMENT; PATIENT MONITORING; PREDICTION AND FORECASTING; PRIORITY JOURNAL; PROTEIN BLOOD LEVEL; REVIEW; VALVULAR HEART DISEASE;

ACUTE DISEASE; AFTERCARE; BIOLOGICAL MARKERS; CARDIO-RENAL SYNDROME; DYSPNEA; EMERGENCY SERVICE, HOSPITAL; HEART FAILURE; HUMANS; MASS SCREENING; NATRIURETIC PEPTIDE, BRAIN; PEPTIDE FRAGMENTS; PREDICTIVE VALUE OF TESTS; PROGNOSIS; RISK ASSESSMENT;

EID: 84863903886     PISSN: 07351097     EISSN: 15583597     Source Type: Journal    
DOI: 10.1016/j.jacc.2012.03.057     Document Type: Review

References (57)

1. K. Maekawa, T. Sudoh, M. Furusawa Cloning and sequence analysis of cDNA encoding a precursor for porcine brain natriuretic peptide Biochem Biophys Res Commun 157 1988 410 416
2. M. Davis, E. Espiner, G. Richards Plasma brain natriuretic peptide in assessment of acute dyspnoea Lancet 343 1994 440 444
3. A.S. Maisel, P. Krishnaswamy, R.M. Nowak Rapid measurement of B-type natriuretic peptide in the emergency diagnosis of heart failure N Engl J Med 347 2002 161 167
4. N.L. Weintraub, S.P. Collins, P.S. Pang Acute heart failure syndromes: emergency department presentation, treatment, and disposition: current approaches and future aims: a scientific statement from the American Heart Association Circulation 122 2010 1975 1996
5. J.L. Januzzi Jr, C.A. Camargo, S. Anwaruddin The N-terminal Pro-BNP Investigation of Dyspnea in the Emergency Department (PRIDE) study Am J Cardiol 95 2005 948 954
6. A.S. Maisel, W.F. Peacock, N. McMullin Timing of immunoreactive B-type natriuretic peptide levels and treatment delay in acute decompensated heart failure: an ADHERE (Acute Decompensated Heart Failure National Registry) analysis J Am Coll Cardiol 52 2008 534 540
7. A. Maisel, J.E. Hollander, D. Guss Primary results of the Rapid Emergency Department Heart Failure Outpatient Trial (REDHOT) A multicenter study of B-type natriuretic peptide levels, emergency department decision making, and outcomes in patients presenting with shortness of breath J Am Coll Cardiol 44 2004 1328 1333
8. C. Mueller, A. Scholer, K. Laule-Kilian Use of B-type natriuretic peptide in the evaluation and management of acute dyspnea N Engl J Med 350 2004 647 654
9. A. Maisel, C. Mueller, R. Nowak Mid-region pro-hormone markers for diagnosis and prognosis in acute dyspnea: results from the BACH (Biomarkers in Acute Heart Failure) trial J Am Coll Cardiol 55 2010 2062 2076
10. M.A. Silver, A. Maisel, C.W. Yancy BNP Consensus Panel 2004: a clinical approach for the diagnostic, prognostic, screening, treatment monitoring, and therapeutic roles of natriuretic peptides in cardiovascular diseases Congest Heart Fail 10 2004 1 30
11. L.B. Daniels, A.S. Maisel Natriuretic peptides J Am Coll Cardiol 50 2007 2357 2368
12. A. Maisel, C. Mueller, K. Adams Jr State of the art: using natriuretic peptide levels in clinical practice Eur J Heart Fail 10 2008 824 839
13. R.R. van Kimmenade, Y.M. Pinto, J.L. Januzzi Jr Importance and interpretation of intermediate (gray zone) amino-terminal pro-B-type natriuretic peptide concentrations Am J Cardiol 101 2008 39 42
14. P.A. McCullough, P. Duc, T. Omland B-type natriuretic peptide and renal function in the diagnosis of heart failure: an analysis from the Breathing Not Properly multinational study Am J Kidney Dis 41 2003 571 579
15. M. Vanderheyden, J. Bartunek, G. Filippatos, M. Goethals, B.V. Vlem, A. Maisel Cardiovascular disease in patients with chronic renal impairment: role of natriuretic peptides Congest Heart Fail 14 2008 38 42
16. V. Cheng, R. Kazanagra, A. Garcia A rapid bedside test for B-type peptide predicts treatment outcomes in patients admitted for decompensated heart failure: a pilot study J Am Coll Cardiol 37 2001 386 391
17. R. Valle, N. Aspromonte, L. Milani Optimizing fluid management in patients with acute decompensated heart failure (ADHF): the emerging role of combined measurement of body hydration status and brain natriuretic peptide (BNP) levels Heart Fail Rev 16 2011 519 529
18. S.U. Rehman, J.L. Januzzi Jr Natriuretic peptide testing in clinical medicine Cardiol Rev 16 2008 240 249
19. S. Di Somma, L. Magrini, V. Pittoni In-hospital percentage BNP reduction is highly predictive for adverse events in patients admitted for acute heart failure: the Italian RED study Crit Care 14 2010 R116
20. D.J. Whellan, C.J. Droogan, J. Fitzpatrick Change in intrathoracic impedance measures during acute decompensated heart failure admission: results from the Diagnostic Data for Discharge in Heart Failure Patients (3D-HF) pilot study J Card Fail 18 2012 107 112
21. A. Maisel Biomonitoring and biomarker-guided therapy: the next step in heart failure and biomarker research J Am Coll Cardiol 58 2011 1890 1892
22. G.M. Felker, V. Hasselblad, A.F. Hernandez, C.M. O'Connor Biomarker-guided therapy in chronic heart failure: a meta-analysis of randomized controlled trials Am Heart J 158 2009 422 430
23. J.L. Januzzi Jr, S.U. Rehman, A.A. Mohammed Use of amino-terminal pro-B-type natriuretic peptide to guide outpatient therapy of patients with chronic left ventricular systolic dysfunction J Am Coll Cardiol 58 2011 1881 1889
24. K. Dickstein, A. Cohen-Solal, G. Filippatos ESC guidelines for the diagnosis and treatment of acute and chronic heart failure 2008: the Task Force for the Diagnosis and Treatment of Acute and Chronic Heart Failure 2008 of the European Society of Cardiology Developed in collaboration with the Heart Failure Association of the ESC (HFA) and endorsed by the European Society of Intensive Care Medicine (ESICM) Eur J Heart Fail 10 2008 933 989
25. S.A. Hunt, W.T. Abraham, M.H. Chin 2009 Focused update incorporated into the ACC/AHA 2005 guidelines for the diagnosis and management of heart failure in adults: a report of the American College of Cardiology Foundation/American Heart Association Task Force on Practice Guidelines developed in collaboration with the International Society for Heart and Lung Transplantation J Am Coll Cardiol 53 2009 e1 e90
26. P. Hildebrandt, P.O. Collinson, R.N. Doughty Age-dependent values of N-terminal pro-B-type natriuretic peptide are superior to a single cut-point for ruling out suspected systolic dysfunction in primary care Eur Heart J 31 2010 1881 1889
27. S. Gupta, A. Rohatgi, C.R. Ayers Risk scores versus natriuretic peptides for identifying prevalent stage B heart failure Am Heart J 161 2011 923 930
28. P.A. Heidenreich, M.A. Gubens, G.C. Fonarow, M.A. Konstam, L.W. Stevenson, P.G. Shekelle Cost-effectiveness of screening with B-type natriuretic peptide to identify patients with reduced left ventricular ejection fraction J Am Coll Cardiol 43 2004 1019 1026
29. J.A. de Lemos, D.K. McGuire, A. Khera Screening the population for left ventricular hypertrophy and left ventricular systolic dysfunction using natriuretic peptides: results from the Dallas Heart Study Am Heart J 157 2009 746 753
30. K. Bibbins-Domingo, R. Gupta, B. Na, A.H. Wu, N.B. Schiller, M.A. Whooley N-terminal fragment of the prohormone brain-type natriuretic peptide (NT-proBNP), cardiovascular events, and mortality in patients with stable coronary heart disease JAMA 297 2007 169 176
31. M.G. Shlipak, J.H. Ix, K. Bibbins-Domingo, F. Lin, M.A. Whooley Biomarkers to predict recurrent cardiovascular disease: the Heart and Soul Study Am J Med 121 2008 50 57
32. J.A. de Lemos, D.A. Morrow, J.H. Bentley The prognostic value of B-type natriuretic peptide in patients with acute coronary syndromes N Engl J Med 345 2001 1014 1021
33. T.J. Wang, M.G. Larson, D. Levy Plasma natriuretic peptide levels and the risk of cardiovascular events and death N Engl J Med 350 2004 655 663
34. P.M. McKie, A. Cataliotti, B.D. Lahr The prognostic value of N-terminal pro-B-type natriuretic peptide for death and cardiovascular events in healthy normal and stage A/B heart failure subjects J Am Coll Cardiol 55 2010 2140 2147
35. R.N. Rodseth, G.A. Lurati Buse, D. Bolliger The predictive ability of pre-operative B-type natriuretic peptide in vascular patients for major adverse cardiac events: an individual patient data meta-analysis J Am Coll Cardiol 58 2011 522 529
36. G. Karthikeyan, R.A. Moncur, O. Levine Is a pre-operative brain natriuretic peptide or N-terminal pro-B-type natriuretic peptide measurement an independent predictor of adverse cardiovascular outcomes within 30 days of noncardiac surgery? A systematic review and meta-analysis of observational studies J Am Coll Cardiol 54 2009 1599 1606
37. G.A. Lurati Buse, M.T. Koller, C. Burkhart, M.D. Seeberger, M. Filipovic The predictive value of preoperative natriuretic peptide concentrations in adults undergoing surgery: a systematic review and meta-analysis Anesth Analg 112 2011 1019 1033
38. M.T. Sandri, M. Salvatici, D. Cardinale N-terminal pro-B-type natriuretic peptide after high-dose chemotherapy: a marker predictive of cardiac dysfunction? Clin Chem 51 2005 1405 1410
39. A.M. Mavinkurve-Groothuis, L. Kapusta, A. Nir, J. Groot-Loonen The role of biomarkers in the early detection of anthracycline-induced cardiotoxicity in children: a review of the literature Pediatr Hematol Oncol 25 2008 655 664
40. S. Aggarwal, M.D. Pettersen, K. Bhambhani, J. Gurczynski, R. Thomas, T. L'Ecuyer B-type natriuretic peptide as a marker for cardiac dysfunction in anthracycline-treated children Pediatr Blood Cancer 49 2007 812 816
41. I. Germanakis, N. Anagnostatou, M. Kalmanti Troponins and natriuretic peptides in the monitoring of anthracycline cardiotoxicity Pediatr Blood Cancer 51 2008 327 333
42. U. Klaar, H. Gabriel, J. Bergler-Klein Prognostic value of serial B-type natriuretic peptide measurement in asymptomatic organic mitral regurgitation Eur J Heart Fail 13 2011 163 169
43. R. Pizarro, O.O. Bazzino, P.F. Oberti Prospective validation of the prognostic usefulness of brain natriuretic peptide in asymptomatic patients with chronic severe mitral regurgitation J Am Coll Cardiol 54 2009 1099 1106
44. I.L. Gerber, R.A. Stewart, M.E. Legget Increased plasma natriuretic peptide levels reflect symptom onset in aortic stenosis Circulation 107 2003 1884 1890
45. P. Lim, J.L. Monin, M. Monchi Predictors of outcome in patients with severe aortic stenosis and normal left ventricular function: role of B-type natriuretic peptide Eur Heart J 25 2004 2048 2053
46. N. Iwahashi, S. Nakatani, S. Umemura, K. Kimura, M. Kitakaze Usefulness of plasma B-type natriuretic peptide in the assessment of disease severity and prediction of outcome after aortic valve replacement in patients with severe aortic stenosis J Am Soc Echocardiogr 24 2011 984 991
47. J. Bergler-Klein, G. Mundigler, P. Pibarot B-type natriuretic peptide in low-flow, low-gradient aortic stenosis: relationship to hemodynamics and clinical outcome: results from the Multicenter Truly or Pseudo-Severe Aortic Stenosis (TOPAS) study Circulation 115 2007 2848 2855
48. R. Pizarro, O.O. Bazzino, P.F. Oberti Prospective validation of the prognostic usefulness of B-type natriuretic peptide in asymptomatic patients with chronic severe aortic regurgitation J Am Coll Cardiol 58 2011 1705 1714
49. T.J. Wang, P. Gona, M.G. Larson Multiple biomarkers for the prediction of first major cardiovascular events and death N Engl J Med 355 2006 2631 2639
50. O. Melander, C. Newton-Cheh, P. Almgren Novel and conventional biomarkers for prediction of incident cardiovascular events in the community JAMA 302 2009 49 57
51. H.C. Kim, P. Greenland, J.E. Rossouw Multimarker prediction of coronary heart disease risk: the Women's Health Initiative J Am Coll Cardiol 55 2010 2080 2091
52. B. Zethelius, L. Berglund, J. Sundstrom Use of multiple biomarkers to improve the prediction of death from cardiovascular causes N Engl J Med 358 2008 2107 2116
53. S. Blankenberg, T. Zeller, O. Saarela Contribution of 30 biomarkers to 10-year cardiovascular risk estimation in 2 population cohorts: the MONICA, risk, Genetics, Archiving, and Monograph (MORGAM) biomarker project Circulation 121 2010 2388 2397
54. R.S. Velagaleti, P. Gona, M.G. Larson Multimarker approach for the prediction of heart failure incidence in the community Circulation 122 2010 1700 1706
55. L.B. Daniels, G.A. Laughlin, P. Clopton, A.S. Maisel, E. Barrett-Connor Minimally elevated cardiac troponin T and elevated N-terminal pro-B-type natriuretic peptide predict mortality in older adults: results from the Rancho Bernardo Study J Am Coll Cardiol 52 2008 450 459
56. S. Blankenberg, M.J. McQueen, M. Smieja Comparative impact of multiple biomarkers and N-Terminal pro-brain natriuretic peptide in the context of conventional risk factors for the prediction of recurrent cardiovascular events in the Heart Outcomes Prevention Evaluation (HOPE) Study Circulation 114 2006 201 208
57. R.B. Schnabel, A. Schulz, C.M. Messow Multiple marker approach to risk stratification in patients with stable coronary artery disease Eur Heart J 31 2010 3024 3031